166 related articles for article (PubMed ID: 12188887)
1. Thymidine phosphorylase: a two-face Janus in anticancer chemotherapy.
Focher F; Spadari S
Curr Cancer Drug Targets; 2001 Aug; 1(2):141-53. PubMed ID: 12188887
[TBL] [Abstract][Full Text] [Related]
2. The rôle of thymidine phosphorylase/PD-ECGF in cancer chemotherapy: a chemical perspective.
Cole C; Foster AJ; Freeman S; Jaffar M; Murray PE; Strafford IJ
Anticancer Drug Des; 1999 Oct; 14(5):383-92. PubMed ID: 10766293
[TBL] [Abstract][Full Text] [Related]
3. Platelet-derived endothelial cell growth factor thymidine phosphorylase in tumour growth and response to therapy.
Griffiths L; Stratford IJ
Br J Cancer; 1997; 76(6):689-93. PubMed ID: 9310231
[TBL] [Abstract][Full Text] [Related]
4. Thymidine phosphorylase-mediated angiogenesis regulated by thymidine phosphorylase inhibitor in human ovarian cancer cells in vivo.
Tsukagoshi S; Saga Y; Suzuki N; Fujioka A; Nakagawa F; Fukushima M; Suzuki M
Int J Oncol; 2003 May; 22(5):961-7. PubMed ID: 12684660
[TBL] [Abstract][Full Text] [Related]
5. Targeting platelet-derived endothelial cell growth factor/thymidine phosphorylase for cancer therapy.
Liekens S; Bronckaers A; Pérez-Pérez MJ; Balzarini J
Biochem Pharmacol; 2007 Dec; 74(11):1555-67. PubMed ID: 17572389
[TBL] [Abstract][Full Text] [Related]
6. The role of thymidine phosphorylase, an angiogenic enzyme, in tumor progression.
Akiyama S; Furukawa T; Sumizawa T; Takebayashi Y; Nakajima Y; Shimaoka S; Haraguchi M
Cancer Sci; 2004 Nov; 95(11):851-7. PubMed ID: 15546501
[TBL] [Abstract][Full Text] [Related]
7. Recent discovery of non-nucleobase thymidine phosphorylase inhibitors targeting cancer.
Bera H; Chigurupati S
Eur J Med Chem; 2016 Nov; 124():992-1003. PubMed ID: 27783978
[TBL] [Abstract][Full Text] [Related]
8. Thymidine phosphorylase inhibitors: recent developments and potential therapeutic applications.
Pérez-Pérez MJ; Priego EM; Hernández AI; Camarasa MJ; Balzarini J; Liekens S
Mini Rev Med Chem; 2005 Dec; 5(12):1113-23. PubMed ID: 16375757
[TBL] [Abstract][Full Text] [Related]
9. Suppression of thymidine phosphorylase-mediated angiogenesis and tumor growth by 2-deoxy-L-ribose.
Uchimiya H; Furukawa T; Okamoto M; Nakajima Y; Matsushita S; Ikeda R; Gotanda T; Haraguchi M; Sumizawa T; Ono M; Kuwano M; Kanzaki T; Akiyama S
Cancer Res; 2002 May; 62(10):2834-9. PubMed ID: 12019161
[TBL] [Abstract][Full Text] [Related]
10. Novel nonsubstrate inhibitors of human thymidine phosphorylase, a potential target for tumor-dependent angiogenesis.
Focher F; Ubiali D; Pregnolato M; Zhi C; Gambino J; Wright GE; Spadari S
J Med Chem; 2000 Jun; 43(13):2601-7. PubMed ID: 10891120
[TBL] [Abstract][Full Text] [Related]
11. Prevention of hypoxia-induced apoptosis by the angiogenic factor thymidine phosphorylase.
Kitazono M; Takebayashi Y; Ishitsuka K; Takao S; Tani A; Furukawa T; Miyadera K; Yamada Y; Aikou T; Akiyama S
Biochem Biophys Res Commun; 1998 Dec; 253(3):797-803. PubMed ID: 9918807
[TBL] [Abstract][Full Text] [Related]
12. [Thymidine phosphorylase and angiogenesis].
Akiyama S
Gan To Kagaku Ryoho; 2000 Jul; 27(8):1208-11. PubMed ID: 10945018
[TBL] [Abstract][Full Text] [Related]
13. Regulation of expression of thymidine phosphorylase/platelet-derived endothelial cell growth factor in human colon carcinoma cells.
Schwartz EL; Wan E; Wang FS; Baptiste N
Cancer Res; 1998 Apr; 58(7):1551-7. PubMed ID: 9537263
[TBL] [Abstract][Full Text] [Related]
14. Interferon induces thymidine phosphorylase/platelet-derived endothelial cell growth factor expression in vivo.
Makower D; Wadler S; Haynes H; Schwartz EL
Clin Cancer Res; 1997 Jun; 3(6):923-9. PubMed ID: 9815767
[TBL] [Abstract][Full Text] [Related]
15. The role of vascular endothelial growth factor-A (VEGF-A) and platelet-derived endothelial cell growth factor/thymidine phosphorylase (PD-ECGF/TP) in Paget's disease of the vulva and breast.
Ellis PE; Wong Te Fong LF; Rolfe KJ; Crow JC; Reid WM; Davidson T; MacLean AB; Perret CW
Anticancer Res; 2002; 22(2A):857-61. PubMed ID: 12014662
[TBL] [Abstract][Full Text] [Related]
16. Platelet-derived endothelial cell growth factor/thymidine phosphorylase concentrations differ in small cell and non-small cell lung cancer.
Yamashita J; Ogawa M; Abe M; Nishida M
Chest; 1999 Jul; 116(1):206-11. PubMed ID: 10424527
[TBL] [Abstract][Full Text] [Related]
17. Platelet-derived endothelial cell growth factor/thymidine phosphorylase expression in normal tissues: an immunohistochemical study.
Fox SB; Moghaddam A; Westwood M; Turley H; Bicknell R; Gatter KC; Harris AL
J Pathol; 1995 Jun; 176(2):183-90. PubMed ID: 7636628
[TBL] [Abstract][Full Text] [Related]
18. Expression of thymidine phosphorylase correlates with microvessel density in prostate cancer.
Kataoka A; Yuasa T; Kageyama S; Iwaki H; Higuchi K; Tanaka T; Okada Y; Yoshiki T
Oncol Rep; 2005 Apr; 13(4):597-600. PubMed ID: 15756429
[TBL] [Abstract][Full Text] [Related]
19. Platelet-derived endothelial cell growth factor/thymidine phosphorylase expression in macrophages correlates with tumor angiogenesis and prognosis in invasive breast cancer.
Nagaoka H; Iino Y; Takei H; Morishita Y
Int J Oncol; 1998 Sep; 13(3):449-54. PubMed ID: 9683777
[TBL] [Abstract][Full Text] [Related]
20. The dual role of thymidine phosphorylase in cancer development and chemotherapy.
Bronckaers A; Gago F; Balzarini J; Liekens S
Med Res Rev; 2009 Nov; 29(6):903-53. PubMed ID: 19434693
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
